homovanillic acid has been researched along with Dyskinesia, Drug-Induced in 68 studies
Homovanillic Acid: A 3-O-methyl ETHER of (3,4-dihydroxyphenyl)acetic acid.
homovanillate : A hydroxy monocarboxylic acid anion which is obtained by deprotonation of the carboxy group of homovanillic acid.
homovanillic acid : A monocarboxylic acid that is the 3-O-methyl ether of (3,4-dihydroxyphenyl)acetic acid. It is a catecholamine metabolite.
Dyskinesia, Drug-Induced: Abnormal movements, including HYPERKINESIS; HYPOKINESIA; TREMOR; and DYSTONIA, associated with the use of certain medications or drugs. Muscles of the face, trunk, neck, and extremities are most commonly affected. Tardive dyskinesia refers to abnormal hyperkinetic movements of the muscles of the face, tongue, and neck associated with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS). (Adams et al., Principles of Neurology, 6th ed, p1199)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Previous studies have variably reported the efficacy of apomorphine in treatment of schizophrenia and tardive dyskinesia." | 9.05 | Apomorphine and schizophrenia. Treatment, CSF, and neuroendocrine responses. ( Davis, BM; Davis, KL; Horvath, TB; Kendler, KS; Levy, MI; Mathé, AA; Mohs, RC; Trigos, G, 1984) |
| "Measurement of plasma prolactin (PRL) concentration and plasma homovanillic acid (HVA) concentration was performed in 24 patients with schizophrenia during maintenance haloperidol treatment." | 7.68 | Plasma prolactin and homovanillic acid as markers for psychopathology and abnormal movements during maintenance haloperidol treatment in male patients with schizophrenia. ( Csernansky, JG; Newcomer, JW; Riney, SJ; Vinogradov, S, 1992) |
| "Plasma prolactin concentration (pPRL), plasma homovanillic acid concentration (pHVA), and symptomatology were measured in 24 male subjects with schizophrenia during maintenance haloperidol treatment." | 5.07 | Plasma prolactin and homovanillic acid as markers for psychopathology and abnormal movements after neuroleptic dose decrease. ( Csernansky, JG; Newcomer, JW; Riney, SJ; Vinogradov, S, 1992) |
| "Previous studies have variably reported the efficacy of apomorphine in treatment of schizophrenia and tardive dyskinesia." | 5.05 | Apomorphine and schizophrenia. Treatment, CSF, and neuroendocrine responses. ( Davis, BM; Davis, KL; Horvath, TB; Kendler, KS; Levy, MI; Mathé, AA; Mohs, RC; Trigos, G, 1984) |
| "Measurement of plasma prolactin (PRL) concentration and plasma homovanillic acid (HVA) concentration was performed in 24 patients with schizophrenia during maintenance haloperidol treatment." | 3.68 | Plasma prolactin and homovanillic acid as markers for psychopathology and abnormal movements during maintenance haloperidol treatment in male patients with schizophrenia. ( Csernansky, JG; Newcomer, JW; Riney, SJ; Vinogradov, S, 1992) |
| "Plasma homovanillic acid (pHVA) levels were measured in 16 chronically ill patients with schizophrenia who also suffered from tardive dyskinesia, and in a group of 14 chronically ill patients with schizophrenia who did not have tardive dyskinesia." | 3.68 | Plasma HVA, tardive dyskinesia and psychotic symptoms in long-term drug-free inpatients with schizophrenia. ( Barbato, G; de Bartolomeis, A; Monteleone, P; Muscettola, G; Pickar, D, 1990) |
| " This review summarises that available pharmacokinetic data involving levodopa, especially as it relates to therapeutic response of parkinsonian patients." | 2.35 | Clinical pharmacokinetics of levodopa in parkinson's disease. ( Bianchine, JR; Shaw, GM, 1976) |
| "Levodopa (l-DOPA, l-3,4-dihydroxyphenylalanine) is the most effective drug in the symptomatic treatment of Parkinson's disease (PD), but chronic use initiates a maladaptive process leading to l-DOPA-induced dyskinesia (LID)." | 1.46 | Cerebrospinal fluid levels of catecholamines and its metabolites in Parkinson's disease: effect of l-DOPA treatment and changes in levodopa-induced dyskinesia. ( Andersen, AD; Binzer, M; Blaabjerg, M; Gramsbergen, JBP; Kamal, A; Kjaer, TW; Stenager, E; Thagesen, H, 2017) |
| " Dosage of concurrent neuroleptics was fixed at least 3 weeks prior to the trial and was unchanged throughout the study period." | 1.29 | B-HT 920, a dopamine D2 agonist, in the treatment of negative symptoms of chronic schizophrenia. ( Inoue, T; Koyama, T; Matsubara, S; Ohmori, T; Yamashita, I, 1993) |
| " Chronic administration of ceruletide (160 micrograms." | 1.29 | Effect of chronic ceruletide treatment on dopaminergic neurotransmitters, receptors and their mRNAs in the striatum of rats with dyskinesia induced by iminodipropionitrile. ( Asanuma, M; Hirata, H; Mori, A; Ogawa, N; Ota, Z, 1993) |
| "In ongoing studies of chronic administration of neuroleptics to monkeys (Cebus apella) and rats, the regional distribution of glutamic acid decarboxylase (GAD) and brain levels of homovanillic acid were examined." | 1.27 | Experimental tardive dyskinesia. ( Gunne, LM; Häggström, JE, 1985) |
| "Pergolide mesylate is a potent dopamine agonist that is being evaluated clinically in Parkinson disease, hyperprolactinemia, and other diseases." | 1.26 | Degree of selectivity of pergolide as an agonist at presynaptic versus postsynaptic dopamine receptors: implications for prevention or treatment of tardive dyskinesia. ( Clemens, JA; Fuller, RW; Hynes, MD, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 41 (60.29) | 18.7374 |
| 1990's | 19 (27.94) | 18.2507 |
| 2000's | 5 (7.35) | 29.6817 |
| 2010's | 3 (4.41) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Morin, N | 1 |
| Morissette, M | 1 |
| Grégoire, L | 1 |
| Di Paolo, T | 3 |
| Andersen, AD | 1 |
| Blaabjerg, M | 1 |
| Binzer, M | 1 |
| Kamal, A | 1 |
| Thagesen, H | 1 |
| Kjaer, TW | 1 |
| Stenager, E | 1 |
| Gramsbergen, JBP | 1 |
| Yabe, H | 1 |
| Choudhury, ME | 1 |
| Kubo, M | 1 |
| Nishikawa, N | 1 |
| Nagai, M | 1 |
| Nomoto, M | 1 |
| Kim, ST | 1 |
| Son, HJ | 1 |
| Choi, JH | 1 |
| Ji, IJ | 1 |
| Hwang, O | 1 |
| Buck, K | 1 |
| Ferger, B | 1 |
| Bishnoi, M | 1 |
| Chopra, K | 1 |
| Kulkarni, SK | 1 |
| Ogawa, T | 1 |
| Nagao, T | 3 |
| Kashiwabara, K | 1 |
| Fujiwara, Y | 1 |
| Harada, T | 1 |
| Otsuki, S | 3 |
| Kolbe, H | 1 |
| Clow, A | 1 |
| Jenner, P | 1 |
| Marsden, CD | 1 |
| Tripodianakis, J | 1 |
| Markianos, M | 1 |
| Garelis, E | 1 |
| Kirch, D | 1 |
| Hattox, S | 1 |
| Bell, J | 1 |
| Murphy, R | 1 |
| Freedman, R | 1 |
| Moore, DC | 2 |
| Glazer, WM | 4 |
| Bowers, MB | 5 |
| Heninger, GR | 2 |
| Naftolin, F | 1 |
| MacLusky, NJ | 1 |
| Arató, M | 2 |
| Bagdy, G | 3 |
| Perényi, A | 3 |
| Béla, A | 1 |
| Jeste, DV | 3 |
| Doongaji, DR | 1 |
| Linnoila, M | 2 |
| Akiyama, K | 1 |
| Yamamoto, M | 1 |
| Fujimoto, A | 1 |
| Ebara, T | 1 |
| Sato, M | 2 |
| Levy, MI | 2 |
| Davis, BM | 2 |
| Mohs, RC | 2 |
| Kendler, KS | 2 |
| Mathé, AA | 2 |
| Trigos, G | 2 |
| Horvath, TB | 2 |
| Davis, KL | 2 |
| Cutler, NR | 1 |
| Kaufmann, CA | 1 |
| Karoum, F | 1 |
| Johns, CA | 1 |
| Fuller, RW | 1 |
| Clemens, JA | 1 |
| Hynes, MD | 1 |
| Szymanski, S | 1 |
| Lieberman, J | 2 |
| Pollack, S | 2 |
| Munne, R | 1 |
| Safferman, A | 1 |
| Kane, J | 2 |
| Kronig, M | 1 |
| Cooper, T | 3 |
| Fornai, F | 1 |
| Alessandri, MG | 1 |
| Saginario, A | 1 |
| Vaglini, F | 1 |
| Corsini, GU | 2 |
| Lieberman, JA | 1 |
| Alvir, J | 1 |
| Geisler, S | 1 |
| Ramos-Lorenzi, J | 1 |
| Woerner, M | 1 |
| Novacenko, H | 1 |
| Kane, JM | 1 |
| Ohmori, T | 1 |
| Koyama, T | 1 |
| Inoue, T | 1 |
| Matsubara, S | 1 |
| Yamashita, I | 1 |
| See, RE | 1 |
| Hirata, H | 1 |
| Ogawa, N | 2 |
| Asanuma, M | 2 |
| Ota, Z | 1 |
| Mori, A | 1 |
| Northoff, G | 1 |
| Wenke, J | 1 |
| Demisch, L | 1 |
| Eckert, J | 1 |
| Gille, B | 1 |
| Pflug, B | 1 |
| Yamada, K | 1 |
| Kanba, S | 1 |
| Ohnishi, K | 1 |
| Ashikari, I | 1 |
| Yagi, G | 1 |
| Asai, M | 1 |
| Sweet, RA | 1 |
| Pollock, BG | 1 |
| Mulsant, BH | 1 |
| Rosen, J | 1 |
| Lo, KH | 1 |
| Yao, JK | 1 |
| Henteleff, RA | 1 |
| Mazumdar, S | 1 |
| Andia, I | 1 |
| Zumarraga, M | 1 |
| Zabalo, MJ | 1 |
| Bulbena, A | 1 |
| Davila, R | 1 |
| Iida, K | 1 |
| Iwata, E | 1 |
| Asanuma, SN | 1 |
| Gómez-Vargas, M | 1 |
| Miyazaki, I | 1 |
| Nakanishi, T | 1 |
| Iacono, RP | 1 |
| Nahab, FB | 1 |
| Nahab, FH | 1 |
| Mohanakumar, KP | 1 |
| Muralikrishnan, D | 1 |
| Thomas, B | 1 |
| Sayers, AC | 2 |
| Bürki, HR | 3 |
| Ruch, W | 2 |
| Asper, H | 2 |
| Winsberg, BG | 2 |
| Hurwic, MJ | 2 |
| Perel, J | 1 |
| Sverd, J | 1 |
| Klutch, A | 1 |
| Roccatagliata, G | 2 |
| Albano, C | 2 |
| Besio, G | 1 |
| Ohshimo, T | 1 |
| Mitsunobu, K | 1 |
| Costentin, J | 1 |
| Klawans, HL | 1 |
| Goetz, C | 1 |
| Nausieda, PA | 1 |
| Weiner, WJ | 1 |
| Cocito, L | 1 |
| Maffini, M | 1 |
| Moore, D | 1 |
| Tarsy, D | 1 |
| Bianchine, JR | 1 |
| Shaw, GM | 1 |
| Lhermitte, F | 1 |
| Rosa, A | 1 |
| Comoy, E | 1 |
| Soininen, H | 1 |
| Laulumaa, V | 1 |
| Helkala, EL | 1 |
| Hartikainen, P | 1 |
| Riekkinen, PJ | 1 |
| Newcomer, JW | 2 |
| Riney, SJ | 2 |
| Vinogradov, S | 2 |
| Csernansky, JG | 2 |
| Lohr, JB | 1 |
| Kuczenski, R | 1 |
| Bracha, HS | 1 |
| Moir, M | 1 |
| Bankiewicz, KS | 1 |
| Plunkett, RJ | 1 |
| Mefford, I | 1 |
| Kopin, IJ | 2 |
| Oldfield, EH | 1 |
| Johansson, PE | 1 |
| Terenius, L | 1 |
| Häggström, JE | 2 |
| Gunne, L | 1 |
| Jolicoeur, FB | 1 |
| Rivest, R | 1 |
| Drumheller, A | 1 |
| Muscettola, G | 1 |
| Barbato, G | 1 |
| de Bartolomeis, A | 1 |
| Monteleone, P | 1 |
| Pickar, D | 1 |
| Saito, T | 1 |
| Ishizawa, H | 1 |
| Tsuchiya, F | 1 |
| Ozawa, H | 1 |
| Takahata, N | 1 |
| Lu, RB | 1 |
| Ko, HC | 1 |
| Lin, WL | 1 |
| Lin, YT | 1 |
| Ho, SL | 1 |
| Johns, C | 1 |
| Charney, DS | 1 |
| Frecska, E | 2 |
| Degrell, I | 1 |
| Mogyorosy, Z | 1 |
| Stahl, SM | 1 |
| Faull, KF | 1 |
| Barchas, JD | 1 |
| Berger, PA | 1 |
| Gunne, LM | 1 |
| Cross, AJ | 1 |
| Crow, TJ | 1 |
| Ferrier, IN | 1 |
| Johnson, JA | 1 |
| Johnstone, EC | 1 |
| Owen, F | 1 |
| Owens, DG | 1 |
| Poulter, M | 1 |
| Révai, K | 1 |
| Kirch, DG | 1 |
| Jaskiw, G | 1 |
| Weinberger, DR | 1 |
| Wyatt, RJ | 1 |
| Lepore, V | 1 |
| Di Reda, N | 1 |
| Defazio, G | 1 |
| Pedone, D | 1 |
| Giovine, A | 1 |
| Lanzi, C | 1 |
| Tartaglione, B | 1 |
| Livrea, P | 1 |
| Bédard, PJ | 2 |
| Boucher, R | 2 |
| Daigle, M | 1 |
| Pintus, S | 1 |
| Chiueh, CC | 1 |
| Weiss, JF | 1 |
| Falardeau, P | 1 |
| Bouchard, S | 1 |
2 reviews available for homovanillic acid and Dyskinesia, Drug-Induced
| Article | Year |
|---|---|
[Modulation of dopaminergic receptor sensitivity in the central nervous system: important parameters in synaptic function regulation].
Topics: Acetylcholine; Adenylyl Cyclases; Animals; Antipsychotic Agents; Apomorphine; Behavior; Corpus Stria | 1979 |
Clinical pharmacokinetics of levodopa in parkinson's disease.
Topics: Carboxy-Lyases; Cardiovascular Diseases; Dopamine; Dose-Response Relationship, Drug; Dyskinesia, Dru | 1976 |
11 trials available for homovanillic acid and Dyskinesia, Drug-Induced
| Article | Year |
|---|---|
CSF monoamine metabolism in patients with tardive dyskinesia: effect of oxypertine and hydroxyzine pamoate.
Topics: Biogenic Amines; Clinical Trials as Topic; Cyclic AMP; Cyclic GMP; Dyskinesia, Drug-Induced; Female; | 1983 |
Apomorphine and schizophrenia. Treatment, CSF, and neuroendocrine responses.
Topics: Adult; Apomorphine; Clinical Trials as Topic; Dyskinesia, Drug-Induced; Growth Hormone; Homovanillic | 1984 |
Apomorphine and schizophrenia.
Topics: Adult; Apomorphine; Dyskinesia, Drug-Induced; Homovanillic Acid; Hormones; Humans; Male; Middle Aged | 1984 |
The dopamine-serotonin relationship in clozapine response.
Topics: Adolescent; Adult; Antipsychotic Agents; Clozapine; Dopamine; Drug Resistance; Dyskinesia, Drug-Indu | 1993 |
Methylphenidate response, psychopathology and tardive dyskinesia as predictors of relapse in schizophrenia.
Topics: Adolescent; Adult; Blinking; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Follow-Up Studie | 1994 |
Catatonia: short-term response to lorazepam and dopaminergic metabolism.
Topics: Acute Disease; Adult; Anti-Anxiety Agents; Anxiety; Catatonia; Depressive Disorder; Dopamine; Dyskin | 1995 |
Association of plasma homovanillic acid with behavioral symptoms in patients diagnosed with dementia: a preliminary report.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antipsychotic Agents; Behavior; Dyskinesia, Drug-Induced | 1997 |
Differential effect of haloperidol and clozapine on plasma homovanillic acid in elderly schizophrenic patients with or without tardive dyskinesia.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Clozapine; Dyskinesia, Drug-Induced; Female; Haloperi | 1998 |
Tardive dyskinesia: a clinical test of the supersensitivity hypothesis.
Topics: Adult; Aged; Clinical Trials as Topic; Cyclic AMP; Depression; Dyskinesia, Drug-Induced; Female; Hom | 1979 |
Plasma prolactin and homovanillic acid as markers for psychopathology and abnormal movements after neuroleptic dose decrease.
Topics: Adult; Aged; Biomarkers; Dose-Response Relationship, Drug; Double-Blind Method; Dyskinesia, Drug-Ind | 1992 |
Plasma amine metabolites before and after withdrawal from neuroleptic treatment in chronic schizophrenic inpatients.
Topics: Adolescent; Adult; Antipsychotic Agents; Brain; Catecholamines; Clinical Trials as Topic; Double-Bli | 1988 |
55 other studies available for homovanillic acid and Dyskinesia, Drug-Induced
| Article | Year |
|---|---|
Effect of a chronic treatment with an mGlu5 receptor antagonist on brain serotonin markers in parkinsonian monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Benserazide; | 2015 |
Cerebrospinal fluid levels of catecholamines and its metabolites in Parkinson's disease: effect of l-DOPA treatment and changes in levodopa-induced dyskinesia.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Aged; Aging; Antiparkinson Agents; Catecholamines; Dopamine; | 2017 |
Zonisamide increases dopamine turnover in the striatum of mice and common marmosets treated with MPTP.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Anticonvulsan | 2009 |
Vertical grid test and modified horizontal grid test are sensitive methods for evaluating motor dysfunctions in the MPTP mouse model of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Biomechanical Phenomena; Chromatography, High | 2010 |
Intrastriatal inhibition of aromatic amino acid decarboxylase prevents l-DOPA-induced dyskinesia: a bilateral reverse in vivo microdialysis study in 6-hydroxydopamine lesioned rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Aromatic-L-Amino-Acid Decarboxylases; Behavior, Animal; Ben | 2008 |
Modulatory effect of neurosteroids in haloperidol-induced vacuous chewing movements and related behaviors.
Topics: Animals; Behavior, Animal; Catalase; Corpus Striatum; Dehydroepiandrosterone Sulfate; Dopamine; Dose | 2008 |
Tardive dyskinesia and neurotransmitters: effects of sodium valproate, cyproheptadine, oxypertine, hydroxyzine pamoate and Ca-hopantenate on monoamine metabolites, cyclic nucleotides and gamma-aminobutyric acid in human cerebrospinal fluid.
Topics: Adult; Aged; Cyclic AMP; Cyclic GMP; Cyproheptadine; Dyskinesia, Drug-Induced; Female; Homovanillic | 1984 |
Neuroleptic-induced acute dystonic reactions may be due to enhanced dopamine release on to supersensitive postsynaptic receptors.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Apomorphine; Dopamine; Dyskinesia, Drug-Induced; Erythrocyt | 1981 |
Neurochemical studies on tardive dyskinesia. I. Urinary homovanillic acid and plasma prolactin.
Topics: Aged; Antipsychotic Agents; Dopamine; Dyskinesia, Drug-Induced; Homovanillic Acid; Humans; Male; Mid | 1983 |
Plasma homovanillic acid and tardive dyskinesia during neuroleptic maintenance and withdrawal.
Topics: Adult; Antipsychotic Agents; Dyskinesia, Drug-Induced; Female; Homovanillic Acid; Humans; Male; Ment | 1983 |
Tardive dyskinesia and plasma homovanillic acid.
Topics: Adult; Age Factors; Aged; Antipsychotic Agents; Brain; Dopamine; Dyskinesia, Drug-Induced; Female; H | 1983 |
The relationship of circulating estradiol to tardive dyskinesia in men and postmenopausal women.
Topics: Antipsychotic Agents; Dyskinesia, Drug-Induced; Estradiol; Female; Homovanillic Acid; Humans; Male; | 1983 |
Comparative neurochemical investigation of tardive dyskinesia and neuroleptic-induced chronic parkinsonism.
Topics: Adult; Antipsychotic Agents; Cyclic AMP; Dyskinesia, Drug-Induced; Homovanillic Acid; Humans; Male; | 1984 |
Elevated cerebrospinal fluid noradrenaline in tardive dyskinesia.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Aged; Antipsychotic Agents; Dyskinesia, Drug-Induced; Homovan | 1984 |
Low-dose apomorphine and bromocriptine in neuroleptic-induced movement disorders.
Topics: Adult; Apomorphine; Bromocriptine; Dyskinesia, Drug-Induced; Female; Homovanillic Acid; Humans; Male | 1983 |
Degree of selectivity of pergolide as an agonist at presynaptic versus postsynaptic dopamine receptors: implications for prevention or treatment of tardive dyskinesia.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Corticosterone; Dopamine; Dose-Response Relationship | 1982 |
beta,beta'-Iminodipropionitrile-induced persistent dyskinetic syndrome in mice is transiently modified by MPTP.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Behavior, Animal; Biogenic Monoamines; Cerebr | 1993 |
B-HT 920, a dopamine D2 agonist, in the treatment of negative symptoms of chronic schizophrenia.
Topics: Arousal; Azepines; Brain; Dopamine Agents; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induce | 1993 |
Assessment of striatal extracellular dopamine and dopamine metabolites by microdialysis in haloperidol-treated rats exhibiting oral dyskinesia.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Animals; Corpus Striatum; Dopamine; Dyskinesia, Drug-In | 1993 |
Effect of chronic ceruletide treatment on dopaminergic neurotransmitters, receptors and their mRNAs in the striatum of rats with dyskinesia induced by iminodipropionitrile.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Benzazepines; Blotting, Northern; Ceruletide; Corpus Striat | 1993 |
Changes in symptoms and plasma homovanillic acid with amantadine hydrochloride in chronic schizophrenia.
Topics: Adult; Aged; Amantadine; Chronic Disease; Dopamine Agents; Dose-Response Relationship, Drug; Drug Ad | 1997 |
Effects of repeated cyclosporin A administration on iminodipropionitrile-induced dyskinesia and TRE-/CRE-binding activities in rat brain.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Cell Nucleus; Corpus Striatum; Cyclic AMP; Cyclospor | 1998 |
Serotonergic decompensation in the akinetic expression of Parkinson's disease.
Topics: Brain; Chromatography, High Pressure Liquid; Dopamine; Dyskinesia, Drug-Induced; Homovanillic Acid; | 2000 |
Neuroprotection by sodium salicylate against 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-induced neurotoxicity.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Ani | 2000 |
Anticholinergic properties of antipsychotic drugs and their relation to extrapyramidal side-effects.
Topics: Animals; Antipsychotic Agents; Atropine; Basal Ganglia Diseases; Clozapine; Corpus Striatum; Drug In | 1976 |
Neurochemistry of withdrawal emergent symptoms in children.
Topics: Antipsychotic Agents; Child; Cyclic AMP; Dyskinesia, Drug-Induced; Homovanillic Acid; Humans; Hydrox | 1977 |
Neurochemistry of withdrawal emergent symptoms in children.
Topics: Antipsychotic Agents; Child; Child, Preschool; Dyskinesia, Drug-Induced; Female; Homovanillic Acid; | 1978 |
[Late chronic dyskinesia from neuroleptic drugs (CSF and pharmacological data) (author's transl)].
Topics: Adult; Antipsychotic Agents; Brain; Dopamine; Dyskinesia, Drug-Induced; Female; Homovanillic Acid; H | 1978 |
Biochemical methods for predicting the occurrence of tardive dyskinesia.
Topics: Amphetamine; Animals; Antipsychotic Agents; Atropine; Caudate Nucleus; Dyskinesia, Drug-Induced; Hal | 1979 |
Cerebrospinal fluid monoamine metabolites and cyclic nucleotides in chronic schizophrenic patients with tardive dyskinesia or drug-induced tremor.
Topics: Adult; Chronic Disease; Cyclic AMP; Cyclic GMP; Cyproheptadine; Dyskinesia, Drug-Induced; Female; Ho | 1979 |
Recent advances in the biochemical pharmacology of extrapyramidal movement disorders.
Topics: Animals; Corpus Striatum; Dopamine; Dyskinesia, Drug-Induced; Homovanillic Acid; Humans; Huntington | 1977 |
Interactions between central monoaminergic systems: dopamine-serotonin.
Topics: Adolescent; Adult; Aged; Bipolar Disorder; Depression; Dopamine; Dyskinesia, Drug-Induced; Female; H | 1979 |
Animal models for tardive dyskinesia: effects of thioridazine.
Topics: Animals; Corpus Striatum; Disease Models, Animal; Dopamine; Dyskinesia, Drug-Induced; Homovanillic A | 1977 |
[Abnormal movements of patients with Parkinsonism treated with L-dopa and anomalies of dopamine metabolism].
Topics: Dopamine; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Female; Homovanillic Acid; Hum | 1977 |
Extrapyramidal signs in Alzheimer's disease: a 3-year follow-up study.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antipsychotic Agents; Basal Ganglia Diseases; Dopamine; | 1992 |
Plasma prolactin and homovanillic acid as markers for psychopathology and abnormal movements during maintenance haloperidol treatment in male patients with schizophrenia.
Topics: Adult; Aged; Apomorphine; Brain; Dyskinesia, Drug-Induced; Haloperidol; Homovanillic Acid; Humans; M | 1992 |
Increased indices of free radical activity in the cerebrospinal fluid of patients with tardive dyskinesia.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Aged; Antipsychotic Agents; Dyskinesia, Drug-Induced; Female; | 1990 |
Behavioral recovery from MPTP-induced parkinsonism in monkeys after intracerebral tissue implants is not related to CSF concentrations of dopamine metabolites.
Topics: Adrenal Medulla; Amnion; Animals; Brain Tissue Transplantation; Caudate Nucleus; Disease Models, Ani | 1990 |
Neuropeptide changes in a primate model (Cebus apella) for tardive dyskinesia.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Brain Chemistry; Cebus; Corpus Striatum; | 1990 |
Hypokinesia, rigidity, and tremor induced by hypothalamic 6-OHDA lesions in the rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Dopamine; Dyskinesia, Drug-Induced; Homovanillic Aci | 1991 |
Plasma HVA, tardive dyskinesia and psychotic symptoms in long-term drug-free inpatients with schizophrenia.
Topics: Aged; Chronic Disease; Dyskinesia, Drug-Induced; Homovanillic Acid; Humans; Male; Middle Aged; Neuro | 1990 |
Neurochemical findings in the cerebrospinal fluid of schizophrenic patients with tardive dyskinesia and neuroleptic-induced parkinsonism.
Topics: Adult; Aged; Antipsychotic Agents; Catecholamines; Dopamine; Dyskinesia, Drug-Induced; Epinephrine; | 1986 |
CSF neurochemical study of tardive dyskinesia.
Topics: Acetylcholinesterase; Dyskinesia, Drug-Induced; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; | 1989 |
Clozapine pharmacology and tardive dyskinesia.
Topics: Adolescent; Adult; Clozapine; Dibenzazepines; Dyskinesia, Drug-Induced; Epinephrine; Female; Homovan | 1989 |
The effect of neuroleptic discontinuation on psychopathology, involuntary movements, and biochemical measures in patients with persistent tardive dyskinesia.
Topics: Antipsychotic Agents; Brain; Dopamine; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; F | 1989 |
Multivariate analysis of monoamine indices in patients with chronic schizophrenia.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Aged; Brain; Dopamine; Dopamine beta-Hydroxylase; Dyskinesia, | 1989 |
CSF monamine metabolites in movement disorders and normal aging.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Aged; Dyskinesia, Drug-Induced; Dystonia; Female; Glycols; Ho | 1985 |
Experimental tardive dyskinesia.
Topics: Animals; Antipsychotic Agents; Brain; Cebus; Corpus Striatum; Disease Models, Animal; Drug Evaluatio | 1985 |
Chemical and structural changes in the brain in patients with movement disorder.
Topics: 3,4-Dihydroxyphenylacetic Acid; Acetylcholine; Antipsychotic Agents; Brain; Choline O-Acetyltransfer | 1985 |
Changes in mental condition, hyperkinesias and biochemical parameters after withdrawal of chronic neuroleptic treatment.
Topics: Adult; Antipsychotic Agents; Dopamine beta-Hydroxylase; Dyskinesia, Drug-Induced; Female; Homovanill | 1985 |
Is there a presynaptic tardive dyskinesia?
Topics: Antipsychotic Agents; Dyskinesia, Drug-Induced; Homovanillic Acid; Humans; Receptors, Dopamine | 1987 |
Dopaminomimetic action of diphenylhydantoin in rat striatum: effect on homovanillic acid and cyclic AMP levels.
Topics: Animals; Apomorphine; Corpus Striatum; Cyclic AMP; Dyskinesia, Drug-Induced; Haloperidol; Homovanill | 1985 |
Physiological doses of estradiol can increase lingual dyskinesia and cerebrospinal fluid homovanillic acid in monkeys.
Topics: Animals; Corpus Striatum; Dopamine; Dyskinesia, Drug-Induced; Estradiol; Female; Homovanillic Acid; | 1985 |
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in mice is enhanced by pretreatment with diethyldithiocarbamate.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Amin | 1985 |
Behavioral and biochemical effect of chronic treatment with D-1 and/or D-2 dopamine agonists in MPTP monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzaze | 1988 |